Teleflex Strengthens Arrow® Pain Management Portfolio with Addition of theAutoFuser® Disposable Pain Pump

Tue Feb 19, 2013 7:30am EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130219:nBw195080a

LIMERICK, Pa.--(Business Wire)--
Teleflex Incorporated (NYSE: TFX) announced today the addition of the AutoFuser®
disposable pain pump to its portfolio of Arrow® pain management products. The
AutoFuser pump is designed to provide an accurate and flexible method to deliver
analgesic medication for continuous peripheral nerve block or site-specific
applications, helping physicians to take control of patients` post-operative
pain to promote faster recovery and reduce overall length of stay. 

The addition of the AutoFuser pain pumps to the Teleflex® portfolio is a result
of the company's recent acquisition of substantially all of the assets of LMA
International N.V. 

"The practice of regional anesthesia continues to grow at an impressive rate,"
said Cary Vance, President, Anesthesia and Respiratory Division. "The addition
of AutoFuser pumps to our portfolio of pain management products, which includes
the Arrow StimuCath® peripheral nerve block catheter, positions Teleflex to
capitalize on this growth while meeting the needs of our core customer." 

AutoFuser pain pumps are available in three different sizes with a selection of
fixed or variable basal infusion rates, allowing physicians to customize their
patients` pain protocol. The parallel bolus feature allows patients to
administer a controlled amount of additional anesthetic to the target site
without interrupting the continuous infusion of medication, providing an
effective method to manage breakthrough pain, which is a common post-operative
challenge. The pump is not manufactured with natural rubber latex, supporting
many hospitals' material safety protocols. 

This new disposable pain pump can be used in conjunction with the recently
released Arrow® FlexBlock continuous peripheral nerve block catheter. The
FlexBlock catheter features an echogenic, coil-reinforced design that offers a
combination of ultrasound visibility, flexibility, and excellent kink
resistance. 

"These two new products further strengthen our presence in the field of pain
management," said Vance. Teleflex`s Arrow Pain Management portfolio includes
peripheral nerve block catheters and needles, peripheral nerve stimulators,
spinal anesthesia trays, and epidural catheters. Learn more at teleflex.com. 

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range
of procedures in critical care and surgery. Our mission is to provide solutions
that enable healthcare providers to improve outcomes and enhance patient and
provider safety. Headquartered in Limerick, PA, Teleflex employs approximately
11,100 people worldwide and serves healthcare providers in more than 130
countries. Additional information about Teleflex can be obtained from the
company's website at teleflex.com. 

Forward-Looking Statements

Any statements contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any forward-looking statements
contained herein are based on our management's current beliefs and expectations,
but are subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to differ
materially from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report on Form
10-K. 

Arrow, StimuCath, FlexBlock, and Teleflex are trademarks or registered
trademarks of Teleflex Incorporated. AutoFuser is a registered trademark of Ace
Medical Co., Ltd. 

©2013 Teleflex Incorporated. All rights reserved. 2013-1771.

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836 



Copyright Business Wire 2013